Jeonjin Bio Co Ltd

Jeonjin Bio Co Ltd maintains a strong liquidity position with a current ratio of 10.83, indicating that its current assets significantly exceed its current liabilities. The company holds KRW 6,411,186,370 in cash and equivalents, which is a substantial portion of its total assets of KRW 18,509,033,930. Despite this, the company reported negative operating income of KRW -293,877,660 and net income of KRW -195,814,040, reflecting operational challenges. The company's return on equity (ROE) is -1.12%, and its return on assets (ROA) is -1.06%, both significantly below the industry norms for Agricultural Chemicals. These metrics suggest that the company is not generating returns that meet the expectations of its equity and asset base. Jeonjin Bio Co Ltd's revenue is derived from the production and sale of harmful animal damage reduction products and insecticide fragrance. The company operates in both domestic and overseas markets, but the input data does not provide specific revenue concentration by segment or geography. Therefore, the extent of geographic or product diversification remains unclear. The company's growth trajectory is uncertain, as the input data does not include forward-looking revenue projections or historical growth rates. However, the negative operating and net income figures indicate that the company is currently not growing profitably. The capital expenditure of KRW -790,755,730 suggests that the company is investing in its operations, but the free cash flow of KRW -451,018,770 indicates that these investments are not yet generating positive cash returns. The risk assessment for Jeonjin Bio Co Ltd indicates low liquidity and dilution risks. The company has no long-term debt and a debt-to-equity ratio of 0, which reduces financial leverage risk. However, the negative operating and net income figures suggest operational risks that could affect future liquidity. There are no immediate filing-based liquidity or dilution flags, indicating that the company is not currently facing significant financial distress. The input data does not include recent filings or transcripts, so there are no specific recent events to report. The company's financial performance and operational challenges suggest that it may need to address its profitability to sustain long-term growth.